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ABSTRACT
Background: The impact of intraoperative ventilation on 
postoperative pulmonary complications is not defined. The 
authors aimed at determining the effectiveness of protective 
mechanical ventilation during open abdominal surgery on 
a modified Clinical Pulmonary Infection Score as primary 
outcome and postoperative pulmonary function.
Methods: Prospective randomized, open-label, clinical trial 
performed in 56 patients scheduled to undergo elective 
open abdominal surgery lasting more than 2 h. Patients were 
assigned by envelopes to mechanical ventilation with tidal 
volume of 9 ml/kg ideal body weight and zero-positive end-
expiratory pressure (standard ventilation strategy) or tidal 
volumes of 7 ml/kg ideal body weight, 10 cm H2O positive 
end-expiratory pressure, and recruitment maneuvers (pro-
tective ventilation strategy). Modified Clinical Pulmonary 
Infection Score, gas exchange, and pulmonary functional 
tests were measured preoperatively, as well as at days 1, 3, 
and 5 after surgery.
Results: Patients ventilated protectively showed better pul-
monary functional tests up to day 5, fewer alterations on 
chest x-ray up to day 3 and higher arterial oxygenation in 
air at days 1, 3, and 5 (mmHg; mean ± SD): 77.1 ± 13.0 
versus 64.9 ± 11.3 (P = 0.0006), 80.5 ± 10.1 versus 69.7 ± 9.3 
(P = 0.0002), and 82.1 ± 10.7 versus 78.5 ± 21.7 (P = 0.44) 
respectively. The modified Clinical Pulmonary Infection 
Score was lower in the protective ventilation strategy at days 
1 and 3. The percentage of patients in hospital at day 28 
after surgery was not different between groups (7 vs. 15% 
respectively, P = 0.42).
Conclusion: A protective ventilation strategy during 
abdominal surgery lasting more than 2 h improved respira-
tory function and reduced the modified Clinical Pulmonary 
Infection Score without affecting length of hospital stay.
What We Already Know about This Topic
•	 The	use	of	large	tidal	volumes	during	mechanical	ventilation	
of	the	lungs	can	injure	the	lungs	of	critically	ill	patients
What This Article Tells Us That Is New
•	 A	 prospective,	 randomized,	 open-label	 trial	 of	 protective	
ventilation	 in	56	patients	undergoing	more	 than	2	h	of	open	
abdominal	surgery	showed	that	lower	tidal	volumes,	positive	
end-expiratory	 pressure,	 and	 recruitment	 maneuvers	 led	 to	
significantly	improved	pulmonary	function	test	results	up	to	5	
days	after	 surgery,	 fewer	chest	 x-ray	 findings	and	 improved	
Clinical	Pulmonary	Infection	Scores
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P OSTOPERATIVE pulmonary complications, espe-cially postoperative respiratory failure, are important 
causes of perioperative morbidity and mortality.1–4 Induc-
tion of general anesthesia promotes a reduction in lung vol-
ume and atelectasis formation associated with a deterioration 
of both gas exchange and respiratory mechanics.5,6 There is 
unequivocal evidence from both experimental and clinical 
studies that mechanical ventilation in critically ill patients 
has the potential to aggravate or even initiate lung injury. 
Two retrospective studies7,8 and one randomized controlled 
trial9 suggested that lower tidal volumes are beneficial in 
patients who need long-term mechanical ventilation but do 
not suffer from lung injury.
Mechanical ventilation is mandatory in patients under-
going general anesthesia. Higher tidal volumes may over-
distend noninjured lungs, in particular, nondependent lung 
tissue. During surgical procedures, both phenomena may 
stress the noninjured lung, triggering local inflammation and 
local coagulation.10,11 Retrospective and prospective studies 
have shown possible beneficial effects of lower tidal volumes 
in patients who are on short-term mechanical ventilation 
because of surgery.12,13 However, the beneficial effects of 
short-term intraoperative mechanical ventilation with lower 
tidal volumes on pulmonary integrity remains undefined.14,15 
In addition, zero-positive end-expiratory pressure (ZEEP) or 
low levels of positive end-expiratory pressure (PEEP) may 
promote atelectasis, resulting in repetitive collapse/reopening 
of dependent lung tissue. The role of PEEP and low tidal 
volume (the so-called protective lung strategy) during the 
intraoperative period in preventing lung damage and post-
operative pulmonary complications is not clearly defined.16,17 
Indeed, recently an experimental study suggested that such 
strategy might even lead to increased inflammation and lung 
injury in normal lungs.18 Despite these pathophysiological 
considerations, the use of PEEP in the operating room is con-
troversial. Recently, an observational study conducted in 28 
centers in France revealed that most patients undergoing gen-
eral surgery were ventilated without PEEP.19 Notably, the use 
of recruitment maneuvers (RMs) to open the lungs has also 
been found to improve the effectiveness of PEEP with regard 
to gas exchange during general anesthesia.20–22 However, to 
date, there is no clear evidence of an additional benefit of 
RMs for routine anesthesia.
The current study compared a lung-protective mechani-
cal ventilation strategy combining the use of lower tidal vol-
ume (Vt), higher PEEP levels, and intraoperative RMs, with 
a conventional standard mechanical ventilation (higher tidal 
volume, ZEEP without intraoperative RMs) during abdomi-
nal nonlaparoscopic surgery lasting more than 2 h.1
We hypothesized that in patients with normal lungs 
scheduled for general anesthesia, a protective ventilation 
strategy might prevent lung function modifications and lung 
morphological alterations.
The aim was to determine in this patient population the 
effect of an intraoperative protective ventilation strategy on 




This unfunded, prospective, randomized, open-label, clinical 
trial was registered at ClinicalTrials.gov (ID NCT00426790). 
This trial was designed to demonstrate a superiority of treat-
ment in protective group compared to the standard group.
The medical ethics committee of the Ospedale di Circolo 
e Fondazione Macchi, Varese, Italy, approved the trial pro-
tocol, and informed consent was obtained from all patients 
before inclusion. The trial was not overseen by an indepen-
dent safety board monitoring due to its design as a pilot 
physiological study.
Inclusion and Exclusion Criteria
Patients scheduled for elective nonlaparoscopic abdominal 
surgery under general anesthesia from May 2006 to May 
2008 were selected through the clinical anesthesia service 
of our regional university hospital—Azienda Ospedaliera 
Ospedale di Circolo e Fondazione Macchi of Varese, Italy.
Patients were eligible for participation if they met the fol-
lowing criteria: nonlaparoscopic abdominal surgery under 
general anesthesia expected to last more than 2 h and age 
more than 18 yr. Exclusion criteria were as follows: body 
mass index more than 40 kg/m2, laparoscopic surgery, need 
for surgery in emergency, previous lung surgery (any), persis-
tent hemodynamic instability, intractable shock considered 
unsuitable for the study by the patient’s managing physician, 
history of chronic obstructive pulmonary disease, repeated 
systemic corticosteroid therapy for acute exacerbations of 
chronic obstructive pulmonary disease, asthma or sleep 
disorders, recent immunosuppressive medication defined 
as need of chemotherapy or radiation therapy, less than 2 
months after chemotherapy or radiation therapy, severe car-
diac disease defined as New York Heart Association class III 
or IV, or acute coronary syndrome, or persistent ventricular 
tachyarrhythmias, pregnancy (excluded by laboratory analy-
sis), acute lung injury or acute respiratory distress syndrome, 
expecting to require prolonged postoperative mechanical 
ventilation, any neuromuscular disease, contraindications to 
position an epidural catheter because of major clotting dis-
orders,23–25 or sign of infection at the site of the procedure.26
Standard Procedures
A central venous line was inserted in all patients, and a 
conservative fluids infusion (12–15 ml⋅kg−1⋅h−1) was 
administered during the study period to assure hemodynamic 
stability. Before they were given general anesthesia, patients 
underwent epidural anesthesia at the T8-T12 level whenever 
not contraindicated. After surgery the patients received a 
continuous infusion of ropivacaine 0.2% at 4–6 ml/h and 
morphine 0.1–0.15 mg for at least 48 h (AmbIT PCA; Summit 
Medical Products, Inc., Sandy, UT) with the possibility of 
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having patient-controlled bolus volume of 4–6 mg/h. The 
catheter was scheduled to be removed on the fourth day after 
surgery. Removal of the epidural catheter was planned at 
least 12 h after the last dose of low–molecular weight heparin 
(Enoxaparine sodium 4,000 U/die in a single subcutaneous 
administration) and 4 h before the next administration.
In other patients analgesia was provided by subcutane-
ous continuous infusion through an elastomeric infusion 
system with morphine (0.3–0.4 mg/kg in 24 h) and ketoro-
lac (1.0–1.5 mg/kg in 24 h) according to creatinine serum 
level. In only one patient analgesia was performed by a con-
tinuous intravenous infusion of ketorolac (60 mg in 24 h) 
and tramadol (300 mg in 24 h); rescue dose was provided 
by subcutaneous morphine (5–10 mg). All patients were 
preoxygenated with FIO2 0.8 before tracheal intubation, and 
maintained at 0.4 during the entire anesthesia procedure, 
irrespective of study group, and received a routine anesthesia 
according to protocol, including intravenous fentanyl (1–
3 μ/kg), propofol (2–3 mg/kg) at induction; thereafter, anes-
thesia was maintained with propofol (5–10 mg⋅kg−1⋅h−1) 
or sevoflurane (inspiratory concentration between 1.5 and 
2%); analgesia was provided with continuous remifentanil 
infusion (0.05–0.3 μ⋅kg−1⋅min−1) or fentanyl (1–3 μ/kg) 
as required. Patients were intubated after they were admin-
istered rocuronium bromide (0.8 mg/kg); rocuronium was 
administered every 40 min, and the last administration 
was at least 1 h before the end of surgical suture. Routine 
intraoperative monitoring was performed using a dedicated 
monitor (IntelliVue Mp70; Philips Electronics, Eindhoven, 
The Netherlands) and included noninvasive blood pressure, 
pulse oximetry, end-tidal fractions of carbon dioxide, and 
electrocardiogram.
According to the standard of care in our institution all 
patients underwent conventional physiotherapy27 (early 
mobilization, stimulation of cough, and incentive spirom-
etry), control of pain to achieve a Visual Analogue Scales 
(VAS) below 3, antibiotic prophylaxis, and antithrombotic 
treatment as required in the postoperative period.
Ventilation Protocol
Concealed randomization was conducted to ensure a fair 
comparison between groups: to select patients for treat-
ment we generated a randomization list by Random Alloca-
tion Software (Windows software, version 1.0, May 2004, 
Saghaei, licensee BioMed Central Ltd.) (allocation ratio 1:1) 
and inserted the group-identification paper in envelopes, 
which were then sealed and clouded to not reveal allocations.
The ventilation protocol consisted of volume-controlled 
mechanical ventilation (Datex Ohmeda S/5 Avance; GE 
Healthcare, Helsinki, Finland) at an inspired oxygen fraction 
of 0.40, inspiratory to expiratory ratio of 1:2, and a respira-
tory rate adjusted to normocapnia (end-tidal carbon dioxide 
partial pressure between 30 and 40 mmHg). The compliance 
value was calculated with the plateau pressure measured dur-
ing the normal ventilation setting, with an inspiratory pause 
set at 40% of the inspiratory time. Patients were randomly 
assigned to mechanical ventilation with either a tidal volume 
of 9 ml/kg ideal body weight (IBW) and ZEEP (the stan-
dard ventilation strategy) or 7 ml/kg IBW and 10 cm H2O 
PEEP with RMs (the protective ventilation strategy). IBW 
was calculated according to a predefined formula: 50 + 0.91 
(height [cm] −152.4) for men and 45.5 + 0.91 (height [cm] 
−152.4) for women.28 RMs, as part of the protective strat-
egy, were performed directly after induction of anesthesia, 
after any disconnection from the mechanical ventilator and 
directly before extubation, in hemodynamic stable situation 
as judged by the attending physician. Briefly, RMs were per-
formed in volume-controlled ventilation as follows: the limit 
of peak inspiratory pressure was initially set at 45 cm H2O, 
the tidal volume at 7 ml/kg IBW, and respiratory rate at 6 
breaths/min, PEEP at 10 cm H2O, and the inspiratory to 
expiratory ratio at 3:1; then the tidal volume was increased 
in steps of 4 ml/kg IBW until plateau pressure reached 30 cm 
H2O and three breaths were allowed. Finally, the respiratory 
rate, the inspiratory to expiratory ratio, inspiratory pause, 
and tidal volume were set back at values preceding the RM, 
whereas the PEEP was maintained at 10 cm H2O.
We defined a remarkable reduction in systolic arterial 
pressure when less than 90 mmHG and ensured that a mean 
arterial pressure less than 60 mmHg was not accepted.
Anesthesiologists were allowed to change the ventilation 
protocol at any point on the surgeon’s request, or if there was 
any concern about patient safety.
Clinical and Laboratory Variables
During mechanical ventilation, airway pressures, tidal vol-
ume, and the respiratory rate were measured by means of the 
facilities of the ventilator. The compliance of the respiratory 
system was calculated as VT/(plateau pressure of the respira-
tory system − PEEP).
Before and after surgery, pulmonary functional tests were 
performed at the bedside by using a spirometer (FERRARIS 
PiKo-6 FEV1/FEV6 METER; Pulmonary Data Services, 
Inc., Louisville, KY) while the patient was in a seated, 
comfortable position. A clip was placed over the nose and the 
patient breathed through the mouth into a tube connected 
to the spirometer. First the patient breathed in deeply, and 
then exhaled as quickly and forcefully as possible into the 
tube. The patient repeated this test three times and the best 
of the three results was considered to be the measure of lung 
function. The forced vital capacity and the forced expiratory 
vital capacity in 1 s were measured whereas the ratio between 
the forced vital capacity and the forced expiratory vital 
capacity in 1 s (forced expiratory vital capacity in 1 s/forced 
vital capacity) was calculated by the internal algorithm of 
the spirometer. We also calculated the predicted values of 
pulmonary functional tests according to Quanjer et al.29
Arterial blood gas analysis (Copenhagen abl 700 series; 
Radiometer, Brønshøj, Denmark) and peripheral oxygen sat-
uration were measured in sitting position in room air, after 
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10 min of adaptation. After surgery, if the patient was using a 
Venturi oxygen mask (Breathing Solutions, Castelbolognese, 
Italy). the mask was removed. If peripheral oxygen satura-
tion dropped below 88% during the 10 min of adaptation, 
the maneuver was stopped and arterial blood gas analysis 
immediately obtained.
Pain Score
Pre- and postoperative dyspnea, cough, presence of secre-
tions, abdominal and thoracic pain were measured by means 
of specifically targeted VAS. VAS was obtained by an attend-
ing physician not involved in the study. Patients were asked to 
report their level of comfort by pointing to a horizontal line, 
100 mm in length, anchored by word descriptor at each end, 
after answering one of the following questions: “How is your 
sensation of dyspnea?”, “How severe was your cough today?”, 
“How is your level of pain?”30,31 The VAS (in millimeters) was 
determined by measuring from the left-hand end of the line 
to the point that the patient or the physician marked.
Chest Radiography
Pre- and postoperative (day 1 and day 3) chest x-ray, per-
formed at the bedside, was examined in a blinded way by an 
independent specialist in radiology, who was not involved in 
the study. Pathological chest x-ray was defined as the pres-
ence of at least one of the following: atelectasis, pleural effu-
sions, or other chest radiological alterations.
Modified Clinical Pulmonary Infection Score
The modified Clinical Pulmonary Infection Score (mCPIS) 
was calculated by a modified original score as described by 
Pelosi et al.32 Patients were also compared before and after 
surgery for the following parameters: the Glasgow Coma 
Scale for nervous central system, the mean arterial pressure 
or administration of vasopressors required for cardiovascu-
lar system, the serum aspartate transaminase, alanine trans-
aminase, and bilirubin for liver, the prothrombin time and 
platelets for coagulation, and the serum creatinine for renal 
system.33
Intraoperative Observations
During the intraoperative period (after induction of anesthe-
sia, during the surgery, and before extubation) the follow-
ing data were collected: airway pressures, arterial pressure, 
compliance of the respiratory system, peripheral oxygen 
saturation, and end-tidal fractions of carbon dioxide. Intra-
operative fluids requirement and erythrocytes administra-
tion were recorded, as well as blood losses and urine output. 
Intraoperative complications were recorded during anesthe-
sia, and defined as follows: peripheral oxygen saturation less 
than 90% and/or end-tidal fractions of carbon dioxide more 
than 45 mmHg for more than 1 min, need to change the 
ventilation setting (tidal volume and/or respiratory rate), 
heart rate more than 100 beats/min or less than 60 beats/
min, systolic arterial pressure more than 150 mmHg or less 
than 90 mmHg, need for vasoactive drugs. During RMs, 
noninvasive blood pressure measurements were performed 
by setting the monitor in continuous mode.
Pre- and Postoperative Observations
Preoperatively the following measurements were obtained: 
peripheral oxygen saturation and arterial blood gas analysis 
in air, pulmonary functional tests, tympanic temperature, 
VAS for abdominal and thoracic pain, dyspnea, cough, pres-
ence of secretions, laboratory tests for organ function, chest 
x-ray, and the mCPIS.
The same measurements were performed on postopera-
tive days 1, 3, and 5 whereas the chest x-ray and the mCPIS 
were calculated only on postoperative days 1 and 3. Pulmo-
nary complications were defined with Celli score34 calcu-
lated postoperatively on days 1, 3, and 5.
Pulmonary complications were defined as the develop-
ment of three or more of six new findings: cough, increased 
secretions, dyspnea, chest pain, temperature greater than 
38°C, and pulse rate more than 100 beats/min.34 Surgical 
complications were recorded and patients were followed 
up until hospital discharge or death. Wound infection was 
defined according to Horan et al.35 criteria: infection within 
30 days after the operative procedure with at least purulent 
drainage from the superficial incision, organisms isolated 
from an aseptically obtained culture of fluid or tissue from 
the superficial incision, with pain or tenderness, localized 
swelling, redness or heat.
Primary and Secondary Endpoints
Our hypothesis was that intraoperative lung-protective ven-
tilation could protect against postoperative pulmonary and 
extrapulmonary complications. The primary endpoints were 
the changes in mCPIS in the postoperative period. The sec-
ondary endpoints were the changes in arterial oxygenation 
and peripheral oxygen saturation in air, the pulmonary func-
tional tests, and the rate of complications during recruit-
ment, anesthesia, as well as in the postoperative period.
Statistical Analysis
The sample size was based on data previously published in 
the literature on oxygenation and chest x-ray alterations 
postoperatively, according to Hedenstierna and Edmark5 
and Choi et al.,10 but a formal a priori sample size calculation 
was not conducted.
The normality of the distribution was tested with the 
D’Agostino-Pearson test. Data are given as mean ± SD or 
median and interquartile range (25–75%), as appropriate. 
Comparisons of normally distributed variables were 
performed with paired or unpaired t tests as appropriate, 
whereas the Mann–Whitney and the Wilcoxon tests were used 
for other variables. Comparisons of two or more proportions 
were conducted with the chi-square test; the Fisher exact test 
was used for small frequencies. The major outcome variables 
were tested with two-way repeated measures ANOVA (group 
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effects), and pair-wise comparisons of each time point with 
baseline, adjusted according to Bonferroni correction, were 
conducted.
The Kaplan–Meier curve was used to analyze the length 
of hospital stay in groups; the log-rank test was used for the 
reported P value.
All tests were two-tailed and statistical significance was 
accepted at P value less than 0.05.
All statistical analyses were performed with MedCalc® 
Version 9.3.7.0 (MedCalc Software bvba, Mariakerke, Bel-
gium). The statistical analysis was performed independently 
of the team of the clinicians involved in the study, by a spe-
cialist in physics and biomedical statistics (Dr. Novario).
Results
Five hundred twenty-seven consecutive patients, who were 
scheduled to undergo an elective surgical procedure of 2 h 
or more, were screened (fig. 1). Four hundred sixty-nine 
patients had one or more exclusion criteria, leaving 58 
patients for randomization. Two patients were excluded 
because of change of surgical plan to videolaparoscopic sur-
gery. Fifty-six were randomized. One patient assigned to 
standard ventilation was excluded due to a severe intraopera-
tive surgical complication leading to a modification in the 
ventilator settings. Fifty-five patients entered the final analy-
sis. There were no major differences between the two groups 
with regard to baseline characteristics (table 1).
Intraoperative Observations
During anesthesia, aside from the mechanical ventilator 
settings, there were no statistically significant differences 
between groups in intraoperative peripheral oxygen satu-
ration, arterial pressure, and fluid balance (table 2). In the 
majority of cases anesthesiologists used sevoflurane to main-
tain anesthesia (26 of 28 cases for the protective ventilation 
Fig. 1. Flow diagram summarizing inclusion, allocation, and analysis. Five hundred twenty-seven patients were observed during 
the study period; 469 patients were excluded due to the presence of one or more exclusion criteria. Fifty-eight patients were 
enrolled; two patients were excluded because of a change in surgical strategy, one patient was excluded for surgical complica-
tion, and finally 55 patients were included for analysis.
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group and 26 of 27 cases for the standard ventilation group; 
P = 1.0). Tidal volume, PEEP, plateau pressure, and mean 
airway pressure of the respiratory system were higher in the 
protective group compared with the standard ventilation 
strategy group. The respiratory rate was slightly lower in the 
standard ventilation strategy group, whereas the end-tidal 
carbon dioxide partial pressure was slightly higher in the 
protective ventilation strategy group.
Overall intraoperative complications, including those 
during RMs, were comparable between the two study groups 
(table 3). During RMs in eight patients systolic arterial pres-
sure decreased less than 90 mmHg for more than 3 min, 
whereas two patients showed a heart rate less than 60 beats/
min. No other complications were observed during RMs. 
End-tidal carbon dioxide partial pressure was never less than 
25 mmHg during RMs.
Postoperative Observations
On postoperative days 1 and 3, the mCPIS was lower in 
the protective as compared with standard ventilation group 
(fig. 2 and table 4). Pulmonary complications34 were higher 
in the standard group compared with the protective group 
on postoperative day 1 (7 of 26 vs. 1 of 27 respectively, P = 
0.024), whereas no differences were found on day 2 (4 of 26 
vs. 2 of 27 respectively, P = 0.42) and day 3 (3 of 26 vs. 1 of 
25 respectively, P = 0.61).
Peripheral oxygen saturation and arterial oxygenation 
decreased on postoperative days 1 and 3 compared with 




(n = 28) P Value
Age, yr (mean ± SD) 67.0 ± 9.0 65.5 ± 11.4 0.94
Sex, M/F 16/11 18/10 0.78
BMI, kg/m2 (mean ± SD) 25.9 ± 4.2 25.0 ± 4.9 0.47
Physical status, n (%)
 ASA I 4 (14.8) 6 (21.3) 0.73
 ASA II 21 (77.8) 19 (67.9) 0.55
 ASA III 2 (7.4) 3 (10.7) 1.0
History of tobacco use, n (%) 10 (37.0) 7 (25.0) 0.39
Type of surgery, n (%)
 Hepatic 3 (11.1) 1 (3.6) 0.35
 Biliary 5 (18.5) 2 (7.1) 0.25
 Gastrointestinal 17 (63.0) 20 (71.4) 0.57
 Other 2 (7.4) 5 (17.9) 0.42
Type of postoperative analgesia, n (%)
 Epidural 19 (70.4) 19 (67.9) 0.92
 Subcutaneous elastomeric infusion system 7 (25.9) 9 (32.1) 0.83
 Intravenous 1 (3.7) 0 (0.0) 0.99
ASA = American Society of Anesthesiology; BMI = body mass index; F = female; M = male.




(n = 28) P Value
VT/IBW, ml/kg (mean ± SD) 9.5 ± 1.1 7.7 ± 0.8 <0.0001
RR, breath/min (mean ± SD) 11.0 ± 1.1 12.8 ± 2.2 <0.0001
Pmax, median [IQR], cm H2O 19.0 [18.0–21.0] 22.0 [19.0–24.0] <0.0001
Pplat, median [IQR], cm H2O 16.0 [14.0–18.0] 18.0 [16.0–22.0] <0.0001
Compliance, median [IQR], ml/cm H2O 40.0 [20.0–40.0] 40.0 [30.0–50.0] 0.45
SpO2, median [IQR], % 99.0 [99.0–100] 99.0 [99.0–100] 0.16
ETCO2, median [IQR], mmHg 30.0 [28.0–31.0] 33.0 [30.0–35.0] <0.0001
Duration of anesthesia, min (mean ± SD) 223.0 ± 80.0 193 ± 64 0.16
Intraoperative blood loss, median [IQR], ml/kg 4.2 [1.8–6.9] 5.1 [2.7–6.8] 0.21
Intraoperative urine output, median [IQR], ml/kg 5.9 [3.3–10.4] 7.5 [5.3–10.3] 0.37
Intraoperative fluid administration, median [IQR], ml/kg 50.0 [37.0–66.0] 46.2 [41.4–65.2] 0.96
Patients receiving blood packed cells, n (%) 3 (11.1) 3 (10.7) 1.0
ETCO2 = end-tidal carbon dioxide; IBW = ideal body weight; IQR = interquartile range; Pmax = peak airway pressure; Pplat = plateau pres-
sure; RR = respiratory rate; SpO2 = oxygen peripheral saturation; VT = tidal volume.
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preoperative period in standard while not in the protective 
ventilation strategy group (figs. 3 and 4). No differences were 
found in PaCO2 and pH between groups up to postoperative 
day 5.
Pulmonary functional tests were comparable preopera-
tively in both groups (table 5). Forced vital capacity and 
forced expiratory vital capacity in 1 s were higher in protec-
tive ventilation strategy group as compared with standard 
ventilation strategy group on postoperative days 1, 3, and 
5. As shown in table 6, in protective compared with stan-
dard ventilation group dyspnea, secretions, and cough scores 
were not different between groups on postoperative days 1, 
3, and 5. Chest x-ray changes were fewer on postoperative 
days 1 and 3 in protective compared with standard ventila-
tion group (fig. 5 and table 7). Finally, pulmonary complica-
tions, as evaluated with the Celli score34 (table 8), were lower 
in the protective ventilation group compared with standard 
ventilation group on postoperative day 1.
No differences were observed in extrapulmonary organ 
function pre- and postoperatively between groups (table 9). 
Also there were no differences in fluids administration and 
hydric balance during postoperative period (table 10).
The Kaplan–Meier curve of hospital length of stay did 
not show statistically significant differences between groups 
(fig. 6; P = 0.96; 95% CI, 0.5775–1.7729). On postopera-
tive day 28, 7% of the patients in the protective ventilation 
strategy group as compared with 15% in the standard venti-
lation strategy group were still recovering in hospital (2 of 28 
patients for protective ventilation group and 4 of 27 patients 
for the standard ventilation group, P = 0.42).
None of the patients died and all were discharged home.
Discussion
In this randomized controlled trial, it was observed that 
in comparison to standard ventilation strategy with higher 
tidal volumes without PEEP and RMs, a lung-protective 
ventilation strategy with lower tidal volumes, 10 cm H2O 
PEEP, and RMs (1) improved mCPIS on postoperative days 
1 and 3; (2) improved postoperative arterial oxygenation and 
pulmonary functional tests; and (3) showed no association 
with an increased incidence of intraoperative complications 
or nonpulmonary organ failures.
Previous randomized controlled trials showed conflict-
ing results regarding the influence of ventilator settings on 
surrogate endpoints of pulmonary and systemic inflam-
mation.10,11,16,17,36–40 These studies were performed in car-
diothoracic surgery,16,37–39,41 in esophagectomy,36 or in a 
nonhomogeneous groups of patients undergoing elective 
surgery.10,11,40 Most of them investigated only the effects on 
the inflammatory response11,40 or alveolar coaugulopathy10 
during mechanical ventilation. RMs were seldom applied in 
most of these studies, and the level of PEEP differed among 
trials. The current trial differs from previous investigations 
with regard to (1) the combination of lower tidal volumes, 
PEEP and RMs—none of the previous investigations eval-
uated potential complications of higher PEEP levels and 
RMs during general anesthesia; (2) the selected population 
Table 3. Intraoperative Complications (Including Those during Recruitment Maneuver)
Standard Ventilation  
(n = 27)
Protective Ventilation  
(n = 28) P Value
SpO2 < 90%, n (%) 0 0 —
ETCO2 > 45 mmHg, n (%) 0 3 (10.7) 0.24
HR > 100 beats/min, n (%) 3 (11.1) 1 (3.6) 0.35
HR < 60 beats/min, n (%) 2 (7.4) 3 (10.7) 1.0
SAP > 150 mmHg, n (%) 3 (11.1) 3 (10.7) 1.0
SAP < 90 mmHg, n (%) 9 (33.3) 15 (53.6) 0.18
Need vasoactive drugs, n (%) 1 (3.7) 0 1.0
ETCO2 = end-tidal carbon dioxide; HR = heart rate; SAP = systolic arterial pressure; SpO2 = oxygen peripheral saturation.
Fig. 2. Modified Clinical Pulmonary Infection Score (mCPIS) in 
standard (red bar) and protective (blue bar) ventilation group 
evaluated on days 0, 1, and 3. * P < 0.05 versus standard ven-
tilation group on days 1 and 3; within the same group †P < 0.05 
versus preoperative period (day 0). Group effect over time P = 
0.001. The individual pair-wise comparisons (Bonferroni cor-
rected) show statistical significance as follows: mCPIS day 1 
P < 0.0002 versus day 0 (95% CI, 0.3367–1.3232) and mCPIS 
day 3 P < 0.0001 versus day 0 (95% CI, 0.5305–1.5169).
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Fig. 3. Peripheral oxygen saturation (SpO2) evaluated on post-
operative days 1, 3, and 5 compared with the preoperative 
period (day 0) in standard (red bar) and protective (blue bar) 
ventilation strategy groups. * P < 0.05 versus standard venti-
lation group on days 1, 3, and 5, respectively; within the same 
group + P <0.05 versus preoperative period (day 0). Group 
effect over time P < 0.001. The individual pair-wise com-
parisons (Bonferroni corrected) show statistical significance 
as follows: SpO2 day 1, P < 0.0001 versus day 0 (95% CI, 
−3.7065 to −1.1086); SpO2 day 3, P < 0.0715 versus day 0 
(95% CI, −2.5362 to 0.06174); SpO2 day 5, P = 1.0 versus day 
0 (95% CI, −1.5850 to 1.0254).
Fig. 4. Arterial oxygen pressure (PaO2) evaluated on postoper-
ative days 1, 3, and 5 compared with the preoperative period 
(day 0) in standard (red bar) and protective (blue bar) ventila-
tion strategy groups. * P < 0.05 versus standard ventilation 
group on days 1, 3, and 5, respectively; within the same group 
+ P < 0.05 versus preoperative period (day 0). Group effect 
over time P < 0.001. The individual pair-wise comparisons 
(Bonferroni corrected) show statistical significance as follows: 
PaO2 on day 1 P < 0.0001 versus on day 0 (95% CI, 21.8521 to 
−9.3786); PaO2 on day 3 P < 0.0001 versus on day 0 (95% CI, 
17.7832 to −5.3096); PaO2 on day 5 P < 0.046 versus on day 
0 (95% CI, 12.6022 to −0.06890).
Table 4. Criteria and Detail Score for Modified Clinical Pulmonary Infection Score on Days 1 and 3 Compared with  
Preoperative Period (Day 0)
Components
Day 0 Day 1 Day 3
Standard Ventilation 
(n = 27)
Protective Ventilation  
(n = 28) P Value
Standard Ventilation  
(n = 26)
Protective Ventilation  
(n = 27) P Value
Standard Ventilation  
(n = 26)
Protective Ventilation  
(n = 27) P Value
Temperature, °C, n (%)
 ≥36.1 and ≤38.4 27 (100) 28 (100) 1.0 26 (100) 27 (100) 1.0 26 (100) 27 (100) 1.0
 ≥38.5 and ≤38.9 0 0 — 0 0 — 0 0 —
 ≥39.0 and ≤36.0 0 0 — 0 0 — 0 0 —
Blood leukocytes, n (%)
 ≥4000 and ≤11.000 26 (96.3) 25 (89.3) 0.61 16 (61.5) 20 (74.1) 0.39 20 (76.9) 24 (88.9) 0.29
 < 4000 and >11.000 1 (3.7) 3 (10.7) 0.31 10 (38.5) 7 (25.9) 0.38 6 (23.1) 3 (11.1) 0.29
Tracheal secretions, n (%)
 Few 24 (88.9) 26 (92.8) 0.67 16 (61.5) 21 (77.8) 0.24 14 (53.8) 21 (77.8) 0.08
 Moderate 3 (11.1) 1 (3.6) 0.35 6 (23.1) 3 (11.1) 0.29 4 (15.4) 3 (11.1) 0.70
 Large 0 1 (3.6) 1.0 4 (15.4) 3 (11.1) 0.70 5 (19.3) 3 (11.1) 0.47
 Purulent 0 0 — 0 0 3 (11.5) 0 0.11
PaO2/FIO2 ratio, mmHg, n (%)
 >240 or presence of ARDS 27 (100) 28 (100) 1.0 24 (92.3) 27 (100) 0.24 26 (100) 27 (100) 1.0
 ≤240 and absence of ARDS 0 0 — 2 (7.7) 0 0.24 0 0 —
Chest x-ray, n (%)
 No infiltrate 25 (92.6) 25 (89.3) 1.0 20 (76.9) 23 (85.2) 0.5 12 (46.2) 22 (81.5) 0.01
 Patchy or diffuse infiltrate 2 (7.4) 3 (10.7) 1 2 (7.7) 2 (7.4) 1.0 7 (26.9) 3 (11.1) 0.17
 Localized infiltrate 0 0 — 4 (15.4) 2 (7.4) 0.42 7 (26.9) 2 (7.4) 0.08
ARDS = acute respiratory distress symdrome; FIO2 = oxygen inspiratory fraction; PaO2 = oxygen arterial pressure.
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of patients undergoing elective abdominal surgical pro-
cedures, the majority lasting more than 2 h with general 
anesthesia; notably, both abdominal surgery and longer 
duration of anesthesia have been reported as potential risk 
factors for higher incidence of postoperative pulmonary 
complications1; (3) standardization of fluid management 
during surgery and in the postoperative period, as well as 
the physiotherapy and analgesic treatments; (4) the cho-
sen endpoints in the postoperative period. From a recent 
survey in France19 the majority (>80% of patients) were 
managed without PEEP, so the use of ZEEP in the control 
group might not be considered unsafe for patients. Fur-
thermore, in our study, 20% of patients underwent hepatic 
or biliary tract surgery, and some concerns might be also 
raised with regard to the use of higher PEEP in this spe-
cific set of patients during surgery. Thus we believe that 
the application of ZEEP and 9 ml/kg tidal volume could 
have been considered as clinical practice at least in our unit 
before the study.
Use of higher PEEP levels is potentially associated with 
an increase in mean airway pressure within the respiratory 
system, likely promoting higher incidence of hemodynamic 
complications, higher fluids’ requirement, and blood losses.
We used tidal volumes of 9 ml/kg in the control arm for 
the following reasons: first, this size of tidal volumes was 
used as a standard in our institution. Second, previous stud-
ies suggested that larger tidal volumes of, e.g., 12 ml/kg could 
cause additional lung injury.9,42
We found that the use of higher PEEP levels was associ-
ated neither with major hemodynamic impairment nor with 
higher intraoperative requirement of fluids or blood losses. 
Nevertheless, use of RMs was associated with no life-threat-
ening reductions in systolic arterial pressure and heart rate, 
but no other complications were observed during RMs.
In the current study we did not use a sustained inflation, 
as commonly suggested. In fact, sustained inflation might 
be associated with more deleterious hemodynamic effects. 
We used a modified RMs by allowing a progressive increase 
in tidal volumes, which may have promoted less negative 
hemodynamic impairment.
In the current trial, our aim was not to investigate major 
postoperative pulmonary complications, but the effects of 
intraoperative ventilation strategies on relevant clinical 
parameters associated with alterations in the pulmonary 
function. We evaluated (1) arterial oxygenation and periph-
eral oxygen saturation in air, (2) pulmonary functional tests, 
(3) changes in dyspnea, cough, and secretions, (4) chest 
x-ray, abnormalities, including atelectasis and pleural effu-
sions, and (5) the mCPIS.
Oxygenation was studied while the patients were breathing 
in air, in seated position, after 10 min of adaptation. This 
allows avoiding any possible influence of different inspiratory 
oxygen fractions on the arterial oxygenation. The pulmonary 
functional tests were studied by using a spirometer while 
the patient was in seated position, allowing reproducible 
measurements. In our study, we standardized the methods 
Table 4. Criteria and Detail Score for Modified Clinical Pulmonary Infection Score on Days 1 and 3 Compared with  
Preoperative Period (Day 0)
Components
Day 0 Day 1 Day 3
Standard Ventilation 
(n = 27)
Protective Ventilation  
(n = 28) P Value
Standard Ventilation  
(n = 26)
Protective Ventilation  
(n = 27) P Value
Standard Ventilation  
(n = 26)
Protective Ventilation  
(n = 27) P Value
Temperature, °C, n (%)
 ≥36.1 and ≤38.4 27 (100) 28 (100) 1.0 26 (100) 27 (100) 1.0 26 (100) 27 (100) 1.0
 ≥38.5 and ≤38.9 0 0 — 0 0 — 0 0 —
 ≥39.0 and ≤36.0 0 0 — 0 0 — 0 0 —
Blood leukocytes, n (%)
 ≥4000 and ≤11.000 26 (96.3) 25 (89.3) 0.61 16 (61.5) 20 (74.1) 0.39 20 (76.9) 24 (88.9) 0.29
 < 4000 and >11.000 1 (3.7) 3 (10.7) 0.31 10 (38.5) 7 (25.9) 0.38 6 (23.1) 3 (11.1) 0.29
Tracheal secretions, n (%)
 Few 24 (88.9) 26 (92.8) 0.67 16 (61.5) 21 (77.8) 0.24 14 (53.8) 21 (77.8) 0.08
 Moderate 3 (11.1) 1 (3.6) 0.35 6 (23.1) 3 (11.1) 0.29 4 (15.4) 3 (11.1) 0.70
 Large 0 1 (3.6) 1.0 4 (15.4) 3 (11.1) 0.70 5 (19.3) 3 (11.1) 0.47
 Purulent 0 0 — 0 0 3 (11.5) 0 0.11
PaO2/FIO2 ratio, mmHg, n (%)
 >240 or presence of ARDS 27 (100) 28 (100) 1.0 24 (92.3) 27 (100) 0.24 26 (100) 27 (100) 1.0
 ≤240 and absence of ARDS 0 0 — 2 (7.7) 0 0.24 0 0 —
Chest x-ray, n (%)
 No infiltrate 25 (92.6) 25 (89.3) 1.0 20 (76.9) 23 (85.2) 0.5 12 (46.2) 22 (81.5) 0.01
 Patchy or diffuse infiltrate 2 (7.4) 3 (10.7) 1 2 (7.7) 2 (7.4) 1.0 7 (26.9) 3 (11.1) 0.17
 Localized infiltrate 0 0 — 4 (15.4) 2 (7.4) 0.42 7 (26.9) 2 (7.4) 0.08
ARDS = acute respiratory distress symdrome; FIO2 = oxygen inspiratory fraction; PaO2 = oxygen arterial pressure.
Table 4. (Continued)
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of performing the chest x-ray at the bedside, and the chest 
x-ray was evaluated by a specialist in radiology, blinded to 
the study. We used a modified CPIS score, as previously 
proposed,32 as an indicator of pulmonary complications.
In our trial we found that the protective ventilation group 
was associated with a statistically significant reduction in chest 
x-ray alterations and mCPIS compared with the standard 
ventilation group. Especially, chest x-ray showed a clinically 
significant increase in postoperative atelectasis on both days 
1 and 3 in the standard ventilation group. This suggests that 
patients ventilated with lower tidal volume and no PEEP in 
our trial could have gross atelectasis and potential peripheral 
airway injury, caused by tidal airway closure, which was main-
tained in the postoperative period. Indeed, a recent experimen-
tal study in open-chest rabbits, demonstrated that mechanical 
ventilation with tidal volumes of 8–12 ml/kg and no PEEP 
causes permanent mechanical alterations and histologic dam-
age to peripheral airways and inflammation in noninjured 
lungs.43 During general anesthesia, atelectasis is potentiated by 
anesthesia and muscle relaxants altering diaphragmatic posi-
tion.5 Also, tidal airway closure can occur and cause peripheral 
Fig. 5. Pathological chest x-ray was defined as the pres-
ence of at least one of the following: atelectasis, pleural 
effusions, or other chest radiological alterations in stan-
dard (red bar) and protective (blue bar) ventilation groups. 
* P < 0.05 versus standard ventilation group on days 1 and 
3; within the same group + P < 0.05 versus preoperative 
period (day 0).
Table 5. Perioperative Pulmonary Functional Tests on Days 1, 3, and 5




























FEV1, l (mean ± SD) 2.02 ± 0.78 1.97 ± 0.68 0.72 1.00 ± 0.36* 1.18 ± 0.42* 1.14 ± 0.45+ 1.45 ± 0.51+ 1.23 ± 0.42§ 1.63 ± 0.55§ <0.001
FEV1 (% predicted), l (mean ± SD) 77.2 ± 22.2 75.4 ± 20.9 0.77 40.2 ± 13.7* 46.48 ± 17.1* 44.5 ± 16.4+ 56.4 ± 18.1+ 47.9 ± 15.7§ 62.6 ± 16.0§ 0.002
FVC, l (mean ± SD) 2.53 ± 0.86 2.53 ± 0.80 0.87 1.31 ± 0.39* 1.48 ± 0.54* 1.45 ± 0.46+ 1.78 ± 0.54+ 1.57 ± 0.47§ 2.02 ± 0.52§ <0.001
FVC (% predicted), l (mean ± SD) 75.9 ± 2.0 77.5 ± 18.2 0.85 41.6 ± 12.1* 47.2 ± 21.7* 45.1 ± 13.3 55.1 ± 17.9 49.0 ± 14.3 61.8 ± 13.4 <0.001
FEV1/FVC, % (mean ± SD) 78.3 ± 11.1 77.1 ± 13.3 0.74 75.8 ± 12.8 82.1 ± 14.2 77.5 ± 10.4 81.29 ± 11.2 77.4 ± 10.5 78.8 ± 13.6 0.124
Values are given as mean and SD.
Group effect was performed by repeated two-way ANOVA. The individual pair-wise comparisons (Bonferroni corrected) show statistical  
significance as follows: *P < 0.0001 vs. FEV1 on day 0. +P < 0.0002 vs. FEV1 on day 0. §P < 0.0098 vs. FEV1 on day 0. *P < 0.0001 vs.  
FEV1 (% predicted) on day 0. +P < 0.0001 vs. FEV1 (% predicted) on day 0. §P < 0.0001 vs. FEV1 (% predicted) on day 0. *P < 0.0001  
vs. FVC on day 0. +P < 0.009 vs. FVC on day 0. §P < 0.009 vs. FVC on day 0. *P < 0.0001 vs. FVC (% predicted) on day 0.
FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity.
Table 6. Perioperative Organ Functional Tests on Days 1, 3, and 5 Compared with the Preoperative Period (Day 0)




























(n = 25) P Value
Dyspnea, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.82 1.0 [0–2.0] 1.0 [0–1.0] 0.13 1.0 [0–2.0] 1.0 [0–1.0] 0.58 1.0 [1.0–2.0] 1.0 [0–1.0] 0.37
Cough, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.49 2 [0–3.0] 1.0 [0–2.0] 0.08 1.0 [0–3.0] 1.0 [0–1.5] 0.16 1.0 [1.0–2.0] 1.0 [0–2.0] 0.07
Secretions, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.64 2 [1.0–3.0] 1.0 [0–2.0] 0.11 2.0 [1–3.0] 1.0 [0–1.5] 0.005 1.0 [1.0–2.0] 0.5 [0–1.0] 0.06
Thorax pain, VAS, median [IQR] 0 [0–0] 0 [0–0] 1 0 [0–1.0] 0 [0–1.0] 0.67 0 [0–0] 0 [0–0] 0.75 0 [0–1.0] 0 [0–1.0] 0.95
Abdominal pain, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.97 2.0 [1.0–3.0] 2.0 [1.0–3.0] 0.98 1.5 [1.0–2.0] 2.0 [1.0–2.0] 0.78 1.0 [1.0–2.0] 1.0 [1.0–2.0] 0.39
Temperature, °C (mean ± SD) 36.5 ± 0.4 36.5 ± 0.3 0.87 36.9 ± 0.7 36.9 ± 0.4 0.53 36.9 ± 0.6 36.6 ± 0.4 0.03 36.7 ± 0.5 36.5 ± 0.3 0.09
Leukocytes, n/mm3 (mean ± SD) 6,780 ± 2,025 6,525 ± 2,448 0.57 11,137 ± 6,036 9,523 ± 2,515 0.38 9,548 ± 3,085 8,877 ± 2,928 0.29 8,623 ± 2,771 8,386 ± 2,453 0.73
IQR = interquartile range; VAS = Visual Analogic Scale.
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airway injury. This may be a common but unrecognized com-
plication in patients undergoing general anesthesia.44 Cyclic 
opening and closing from ZEEP leads to greater increases in 
bronchoalveolar lavage cytokines than atelectasis.45
Furthermore, these morphological alterations were associ-
ated with a marked improvement in arterial oxygenation in 
air as well as better pulmonary functional tests in the protec-
tive ventilation strategy group. Interestingly, in the protective 
ventilation group compared with the standard ventilation 
group, on postoperative day 1, we observed a lower per-
centage of patients with an arterial oxygenation less than 60 
mmHg (3.6 vs. 18.5% respectively). Similarly, we observed a 
lower percentage of patients with peripheral oxygen satura-
tion levels less than 90% in air (3.6 vs. 19.2% respectively, P = 
0.1). Our results suggest therefore that intraoperative protec-
tive ventilation strategy may play a relevant role to minimize 
potential oxygen desaturation in the postoperative period.
Although the study was intentionally not powered for out-
come, the improvement in these clinical variables was not asso-
ciated with a statistically significant reduction in the hospital 
length of stay in the protective ventilation group. However, in 
our study, on postoperative day 14, 20% of the patients in the 
protective ventilation strategy group as compared with 40% in 
the standard ventilation strategy group were in hospital.
The current trial suffers of some potential limitations, 
which need to be addressed. First, our study does not allow 
to differentiate the effects of lower tidal volumes from those 
of higher PEEP levels. We deliberately chose to combine 
lower tidal volumes with higher PEEP levels as well as RMs 
to identify a ventilation strategy aimed at keeping the lung 
open during general anesthesia for surgery, a strategy that 
might have potential benefits in the postoperative period. Sec-
ond, we performed the RMs until plateau pressure reached 
30 cm H2O for three breaths, but we had not systematically 
recorded the peak pressures reached during the RM. Third, 
we did not focus on the effects of ventilation strategies on 
major postoperative pulmonary complications. The mCPIS 
includes the evaluation of the chest x-ray. It has been reported 
that chest x-ray may underestimate the presence of atelectasis 
and lung morphology alterations as compared with computed 
tomography.46 However, computed tomography is not easy 
to obtain in this group of patients for technical and ethical 
Table 5. Perioperative Pulmonary Functional Tests on Days 1, 3, and 5




























FEV1, l (mean ± SD) 2.02 ± 0.78 1.97 ± 0.68 0.72 1.00 ± 0.36* 1.18 ± 0.42* 1.14 ± 0.45+ 1.45 ± 0.51+ 1.23 ± 0.42§ 1.63 ± 0.55§ <0.001
FEV1 (% predicted), l (mean ± SD) 77.2 ± 22.2 75.4 ± 20.9 0.77 40.2 ± 13.7* 46.48 ± 17.1* 44.5 ± 16.4+ 56.4 ± 18.1+ 47.9 ± 15.7§ 62.6 ± 16.0§ 0.002
FVC, l (mean ± SD) 2.53 ± 0.86 2.53 ± 0.80 0.87 1.31 ± 0.39* 1.48 ± 0.54* 1.45 ± 0.46+ 1.78 ± 0.54+ 1.57 ± 0.47§ 2.02 ± 0.52§ <0.001
FVC (% predicted), l (mean ± SD) 75.9 ± 2.0 77.5 ± 18.2 0.85 41.6 ± 12.1* 47.2 ± 21.7* 45.1 ± 13.3 55.1 ± 17.9 49.0 ± 14.3 61.8 ± 13.4 <0.001
FEV1/FVC, % (mean ± SD) 78.3 ± 11.1 77.1 ± 13.3 0.74 75.8 ± 12.8 82.1 ± 14.2 77.5 ± 10.4 81.29 ± 11.2 77.4 ± 10.5 78.8 ± 13.6 0.124
Values are given as mean and SD.
Group effect was performed by repeated two-way ANOVA. The individual pair-wise comparisons (Bonferroni corrected) show statistical  
significance as follows: *P < 0.0001 vs. FEV1 on day 0. +P < 0.0002 vs. FEV1 on day 0. §P < 0.0098 vs. FEV1 on day 0. *P < 0.0001 vs.  
FEV1 (% predicted) on day 0. +P < 0.0001 vs. FEV1 (% predicted) on day 0. §P < 0.0001 vs. FEV1 (% predicted) on day 0. *P < 0.0001  
vs. FVC on day 0. +P < 0.009 vs. FVC on day 0. §P < 0.009 vs. FVC on day 0. *P < 0.0001 vs. FVC (% predicted) on day 0.
FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity.
Table 6. Perioperative Organ Functional Tests on Days 1, 3, and 5 Compared with the Preoperative Period (Day 0)




























(n = 25) P Value
Dyspnea, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.82 1.0 [0–2.0] 1.0 [0–1.0] 0.13 1.0 [0–2.0] 1.0 [0–1.0] 0.58 1.0 [1.0–2.0] 1.0 [0–1.0] 0.37
Cough, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.49 2 [0–3.0] 1.0 [0–2.0] 0.08 1.0 [0–3.0] 1.0 [0–1.5] 0.16 1.0 [1.0–2.0] 1.0 [0–2.0] 0.07
Secretions, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.64 2 [1.0–3.0] 1.0 [0–2.0] 0.11 2.0 [1–3.0] 1.0 [0–1.5] 0.005 1.0 [1.0–2.0] 0.5 [0–1.0] 0.06
Thorax pain, VAS, median [IQR] 0 [0–0] 0 [0–0] 1 0 [0–1.0] 0 [0–1.0] 0.67 0 [0–0] 0 [0–0] 0.75 0 [0–1.0] 0 [0–1.0] 0.95
Abdominal pain, VAS, median [IQR] 0 [0–0] 0 [0–0] 0.97 2.0 [1.0–3.0] 2.0 [1.0–3.0] 0.98 1.5 [1.0–2.0] 2.0 [1.0–2.0] 0.78 1.0 [1.0–2.0] 1.0 [1.0–2.0] 0.39
Temperature, °C (mean ± SD) 36.5 ± 0.4 36.5 ± 0.3 0.87 36.9 ± 0.7 36.9 ± 0.4 0.53 36.9 ± 0.6 36.6 ± 0.4 0.03 36.7 ± 0.5 36.5 ± 0.3 0.09
Leukocytes, n/mm3 (mean ± SD) 6,780 ± 2,025 6,525 ± 2,448 0.57 11,137 ± 6,036 9,523 ± 2,515 0.38 9,548 ± 3,085 8,877 ± 2,928 0.29 8,623 ± 2,771 8,386 ± 2,453 0.73
IQR = interquartile range; VAS = Visual Analogic Scale.
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(n = 25) P Value
Cough, n (%) 2 (7.4) 2 (7.1) 1.0 8 (30.8) 4 (14.8) 0.20 7 (26.9) 5 (18.5) 0.53 9 (34.6) 7 (28.0) 0.76
Increased secretions, n (%) 3 (11.1) 2 (7.1) 0.67 10 (38.5) 6 (22.2) 0.24 12 (46.2) 6 (22.2) 0.09 10 (38.5) 3 (12.0) 0.05
Dyspnea, n (%) 0 0 — 8 (30.8) 3 (11.1) 0.1 3 (11.5) 5 (18.5) 0.70 2 (7.7) 3 (12.0) 0.67
Chest pain, n (%) 0 0 — 2 (7.7) 1 (3.7) 0.61 0 1 (3.7) 1.0 0 1 (4.0) 0.49
Temperature >38°C, n (%) 0 0 — 2 (7.7) 0 0.24 1 (3.8) 0 0.49 1 (3.8) 0 1.0
HR >100 beats/min, n (%) 0 1 (3.6) 1.0 3 (11.5) 0 0.11 2 (7.7) 0 0.23 1 (3.8) 0 1.0
HR = heart rate.
Table 9. Perioperative Laboratory Tests on Days 1, 3, and 5 Compared with the Preoperative Period (Day 0)


























(n = 25) P Value
Bilirubine, mg/dl (mean ± SD) 2.4 ± 4.2 2.4 ± 4.6 0.71 2.7 ± 4.9 2.6 ± 4.4 0.92 2.5 ± 4.6 2.4 ± 4.5 0.06 2.4 ± 4.0 7.8 ± 27.8 0.97
AST (mean ± SD) 29.9 ± 22.7 30.7 ± 25.5 0.53 46.2 ± 46.3 43.4 ± 40.2 0.81 36.2 ± 23.5 36.4 ± 40.3 0.33 30.3 ± 17.9 32.6 ± 20.3 0.55
ALT (mean ± SD) 39.0 ± 45.1 39.6 ± 52.9 0.46 49.9 ± 51.9 45.2 ± 37.7 0.77 37.4 ± 35.8 47.9 ± 68.4 0.60 33.6 ± 22.3 42.6 ± 42.5 0.53
Platelets, n/mm3 (mean ± SD) 260.8 ± 92.9 279.3 ± 112.9 0.63 240.5 ± 78.7 250.1 ± 104.7 0.79 235.5 ± 86.3 246.4 ± 107.7 0.93 261.0 ± 107.1 258.6 ± 109.7 0.87
PTT, s (mean ± SD) 24.9 ± 2.6 25.9 ± 2.6 0.27 25.18 ± 3.61 27.3 ± 5.6 0.04 26.8 ± 2.9 26.2 ± 2.4 0.19 26.9 ± 3.7 25.3 ± 5.2 0.47
PT, INR (mean ± SD) 1.0 ± 0.1 1.1 ± 0.2 0.85 1.2 ± 0.2 1.2 ± 0.1 1.0 1.2 ± 0.2 1.2 ± 0.2 0.52 1.2 ± 0.2 1.1 ± 0.1 0.65
Serum creatinine, mg/dl (mean ± SD) 1.0 ± 0.1 1.1 ± 0.3 0.22 1.1 ± 0.2 1.1 ± 0.4 0.94 1.1 ± 0.3 1.0 ± 0.4 0.58 1.1 ± 0.3 1.1 ± 0.3 0.67
ALT = alanine transaminase; AST = aspartate transaminase; INR = international normalized ratio; PT = prothrombin time; PTT = partial 
thromboplastin time.
Table 10. Postoperative Fluids Management on Days 1, 2, and 3


















(n = 27) P Value
Hydric balance, ml⋅kg−1⋅h−1 (mean ± SD) 0.51 ± 0.32 0.37 ± 0.41 0.17 0.35 ± 0.46 0.19 ± 0.45 0.26 0.28 ± 0.38 0.23 ± 0.50 0.64
Fluid administration, ml kg−1 h−1 (mean ± SD) 1.67 ± 0.54 1.73 ± 0.50 0.74 1.69 ± 0.54 1.81 ± 0.52 0.41 1.64 ± 0.53 1.79 ± 0.52 0.23
Diuresis, ml kg−1 h−1 (mean ± SD) 1.05 ± 0.48 1.21 ± 0.49 0.11 1.22 ± 0.69 1.46 ± 0.59 0.09 1.21 ± 0.47 1.42 ± 0.47 0.06
Table 7. Pathological Chest x-ray Tests on Days 1 and 3 Compared with the Preoperative Period (Day 0)




(n = 28) P Value
Standard Ventilation  
(n = 26)
Protective Ventilation 




(n = 27) P Value
Normal, n (%) 23 25 0.7 16 23 0.07 7 18 0.005
Increased thickness of interstitium, n (%)  2  2 1.0  1  1 1.0 3  1 0.35
Disventilatory areas including minimal density change, n (%)  0  1 1.0  1  1 1.0 4  2 0.42
Atelectasis, n (%)  0  0 1.0  4  2 0.42 7  2 0.07
Pleural effusions, n (%)  2  0 0.24  4  0 0.05 5  4 0.73
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(n = 25) P Value
Cough, n (%) 2 (7.4) 2 (7.1) 1.0 8 (30.8) 4 (14.8) 0.20 7 (26.9) 5 (18.5) 0.53 9 (34.6) 7 (28.0) 0.76
Increased secretions, n (%) 3 (11.1) 2 (7.1) 0.67 10 (38.5) 6 (22.2) 0.24 12 (46.2) 6 (22.2) 0.09 10 (38.5) 3 (12.0) 0.05
Dyspnea, n (%) 0 0 — 8 (30.8) 3 (11.1) 0.1 3 (11.5) 5 (18.5) 0.70 2 (7.7) 3 (12.0) 0.67
Chest pain, n (%) 0 0 — 2 (7.7) 1 (3.7) 0.61 0 1 (3.7) 1.0 0 1 (4.0) 0.49
Temperature >38°C, n (%) 0 0 — 2 (7.7) 0 0.24 1 (3.8) 0 0.49 1 (3.8) 0 1.0
HR >100 beats/min, n (%) 0 1 (3.6) 1.0 3 (11.5) 0 0.11 2 (7.7) 0 0.23 1 (3.8) 0 1.0
HR = heart rate.
Table 9. Perioperative Laboratory Tests on Days 1, 3, and 5 Compared with the Preoperative Period (Day 0)
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Platelets, n/mm3 (mean ± SD) 260.8 ± 92.9 279.3 ± 112.9 0.63 240.5 ± 78.7 250.1 ± 104.7 0.79 235.5 ± 86.3 246.4 ± 107.7 0.93 261.0 ± 107.1 258.6 ± 109.7 0.87
PTT, s (mean ± SD) 24.9 ± 2.6 25.9 ± 2.6 0.27 25.18 ± 3.61 27.3 ± 5.6 0.04 26.8 ± 2.9 26.2 ± 2.4 0.19 26.9 ± 3.7 25.3 ± 5.2 0.47
PT, INR (mean ± SD) 1.0 ± 0.1 1.1 ± 0.2 0.85 1.2 ± 0.2 1.2 ± 0.1 1.0 1.2 ± 0.2 1.2 ± 0.2 0.52 1.2 ± 0.2 1.1 ± 0.1 0.65
Serum creatinine, mg/dl (mean ± SD) 1.0 ± 0.1 1.1 ± 0.3 0.22 1.1 ± 0.2 1.1 ± 0.4 0.94 1.1 ± 0.3 1.0 ± 0.4 0.58 1.1 ± 0.3 1.1 ± 0.3 0.67
ALT = alanine transaminase; AST = aspartate transaminase; INR = international normalized ratio; PT = prothrombin time; PTT = partial 
thromboplastin time.
Table 10. Postoperative Fluids Management on Days 1, 2, and 3
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Diuresis, ml kg−1 h−1 (mean ± SD) 1.05 ± 0.48 1.21 ± 0.49 0.11 1.22 ± 0.69 1.46 ± 0.59 0.09 1.21 ± 0.47 1.42 ± 0.47 0.06
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Anesthesiology 2013; 118:1307-21 1320 Severgnini et al.
Protective Ventilation during Abdominal Surgery
reasons. Fourth, our data cannot be directly translated to other 
categories of patients and types of surgery. Fifth, with regard 
to anesthesia conduction, several studies suggest that volatile 
anesthetics could modify the inflammatory process in general 
and we cannot exclude this as having affected our outcomes. 
Moreover, a recent study shows an induced inflammatory 
response from halogenated anesthetics versus propofol, which 
seems to preserve antiinflammatory and antioxidant defences 
during mechanical ventilation in pigs model, preventing the 
emergence of apoptosis.47 In contrast, several other studies 
show that halogenated anesthesia attenuates the inflammatory 
response.48,49 Another recent study, concerning the inflam-
matory response in major abdominal surgery, reveals that 
there are no statistically significant differences between total 
intravenous anesthesia and inhalational anesthesia.50 Finally, 
the baseline pulmonary functional test results were a bit lower 
than predicted, likely due to the method of measurement. 
However, we believe that this did not affect the interpretation 
of our data, because we investigated the evolution of pulmo-
nary functional tests with time in the two study groups.
In conclusion, we showed that a protective ventilation 
strategy with lower tidal volumes, PEEP, and RMs during 
anesthesia improved the respiratory function in the postop-
erative period after abdominal nonlaparoscopic surgery and 
reduced the clinical signs of pulmonary infection during the 
first 5 days after open abdominal surgery. Larger trials are 
warranted to determine whether intraoperative protective 
mechanical ventilation improves major outcome parameters.
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